1 |
Cox JD, Stetz J, Pajak TF (1995). Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys, 31, 1341-6.
DOI
|
2 |
GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012, World Health Organization. Available from http://www.globocan.iarc.fr/old/FactSheets/cancers/cervix-new.aspx. [last accessed on 4 November 2014].
|
3 |
Hashim N, Jamalludin Z, Ung NM, et al (2014). CT based 3-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: comparison between dose-volume histograms and ICRU point doses to the rectum and bladder. Asian Pac J Cancer Prev, 15, 5259-64.
DOI
|
4 |
ICRU Report #38 (1985). Dose and volume specification for reporting intracavitary therapy in oncology. International Commission on Radiation Units and Measurements. Bethesda, MD:1.
|
5 |
Kumaran A, Guruvare S, Sharan K, et al (2014). Chemoradiation related acute morbidity in carcinoma cervix and correlation with hematologic toxicity: a South Indian prospective study. Asian Pac J Cancer Prev, 15, 4483-6.
DOI
|
6 |
Madan R, Pathy S, Subramani V, et al. (2014). Comparative evaluation of two-dimensional radiography and three dimensional computed tomography based dose-volume parameters for high-dose-rate intracavitary brachytherapy of cervical cancer: a prospective study. Asian Pac J Cancer Prev, 15, 4717-21.
DOI
|
7 |
Nag S, Erickson B, Thomadsen B, Orton C, Demanes JD, Petereit D (2000). The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys, 48, 201-11.
|
8 |
Orton GC (1995). Width of the therapeutic window: What is the optimal dose-per-fraction for high dose rate cervix cancer brachytherapy? Int J Radiat Oncol Biol Phys, 31, 1011-3.
DOI
|
9 |
Patel FD, Kumar P, Karunanidhi G, Sharma SC, Kapoor R (2011). Optimization of high-dose-rate intracavitary brachytherapy schedule in the treatment of carcinoma of the cervix. Brachytherapy, 2, 147-53.
|
10 |
Patel FD, Rai B, Mallick I, Sharma SC (2005). High-dose-rate brachytherapy in uterine cervical carcinoma. Int J Radiat Oncol Biol Phys, 62, 125-30.
DOI
|
11 |
Shruthi PS, Kalyani R, Kai LJ, et al (2014). Clinicopathological correlation of cervical carcinoma: a tertiary hospital based study. Asian Pac J Cancer Prev, 15, 1671-4.
DOI
|
12 |
Sood BM, Gorla G, Gupta S, et al (2002). Two fractions of high-dose-rate brachytherapy in the management of cervix cancer: clinical experience with and without chemotherapy. Int J Radiat Oncol Biol Phys, 53, 702-6.
DOI
|